Fortis Cancer Care Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 1.50 M
as on 23-10-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -7.95%
(FY 2023)
- Ebitda -10.66%
(FY 2023)
- Net Worth -7.78%
(FY 2023)
- Total Assets -24.12%
(FY 2023)
About Fortis Cancer Care
The Corporate was formerly known as Fortis Health Management (South) Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rajeev Dua, Anurag Kalra, and Ajey Maharaj serve as directors at the Company.
- CIN/LLPIN
U85110HR2011PLC084071
- Company No.
084071
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2011
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Fortis Cancer Care?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Dua  | Director | 23-Dec-2015 | Current |
| Anurag Kalra | Director | 01-Oct-2014 | Current |
| Ajey Maharaj | Director | 10-Jul-2020 | Current |
Financial Performance and Corporate Structure Insights of Fortis Cancer Care.
Fortis Cancer Care Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 7.95% decrease in profit. The company's net worth dipped by a decrease of 7.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fortis Cancer Care?
In 2023, Fortis Cancer Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Stellant Capital Advisory Services Private LimitedActive 19 years 7 monthsRajeev Dua is a mutual person
- Fortis Health Management (East) LimitedActive 13 years 8 months
Rajeev Dua and Ajey Maharaj are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fortis Cancer Care?
Unlock and access historical data on people associated with Fortis Cancer Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fortis Cancer Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortis Cancer Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
